Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Needle Free Injection Companies

Needle-free injection technology offers an alternative to traditional needle-based methods for delivering medications or vaccines. Several companies are actively involved in the development and commercialization of needle-free injection devices.

Needle Free Injection Key CompaniesLatest Needle Free Injection Companies Update



  • June 2023: Prejex Inc., a subsidiary of Prejex GMBH based in Germany, announced that it and Polybond have reached a manufacturing agreement for needleless injections. This collaboration has facilitated the relocation of the German company's manufacturing operations from Berlin to Pune, with the intention of facilitating worldwide distribution. It was asserted that the Prejex-Polybond factory would produce needleless injections for the entire globe. The needleless injection-based New Drug Delivery System (NDDS) from Prejex is an innovation of the highest caliber that has been eagerly anticipated by the medical community. Prejex offers solutions to numerous challenges encountered by professionals in the course of their daily activities. The cost of disposing of syringes and disposable needles, which are significant contributors to hazardous waste, is through the roof. Trypanophobia, which refers to an intense aversion to needles, frequently influences patients' refusal to consent to blood draws, vaccinations, or intravenous fluid administration.




  • September 2023: Today, Scancell, a collaborative venture of PharmaJet®, which develops precision delivery systems to surmount the obstacles associated with administering pharmaceuticals and vaccines, received favorable results from the initial phase of its Phase 2 clinical trial targeting patients with unresectable advanced melanoma. Patients prefer the needleless injection method of administering the vaccine via the PharmaJet Stratis® System to the needle and syringe methods. Throughout history, patients diagnosed with unresectable stage III and IV melanoma, in cases where surgery is not feasible, have had a dismal prognosis: The mean duration of survival is a mere 6.2 months (1). Scancell's immunotherapy platform endeavors to enhance this prognosis by leveraging the immune system's capability to detect, eliminate, and combat malignancies.


List of Needle Free Injection Key companies in the market

  • CROSSJECT

  • Medical International Technology, Inc.

  • National Medical Products Inc.

  • INJEX Pharma GmBH

  • PenJet Corporation

  • Valeritas Holdings, Inc.

  • Antares Pharma Inc.

  • D'Antonio Consultants International, Inc.

  • MIKA MEDICAL CO.

  • PharmaJet, Inc.

  • Endo Pharmaceuticals Inc.

  • Inovio Pharmaceuticals Inc

  • European Pharma Group

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.